Clinical Trial Update: Comparison of 25mg Versus 5 mg Lenalidomide as Maintenance Therapy in Patients With Multiple Myeloma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial compared 25 mg versus 5 mg lenalidomide as maintenance therapy in multiple myeloma and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

Sponsor: Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED